Financing

Proceeds from issuance of common stock relating to employee stock plans

Elevance Health Proceeds from issuance of common stock relating to employee stock plans remained flat by 0.0% to $19.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 64.3%, from $55.25M to $19.75M. Over 3 years (FY 2022 to FY 2025), Proceeds from issuance of common stock relating to employee stock plans shows a downward trend with a -24.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025Feb 6, 2026

How to read this metric

Higher proceeds generally correlate with higher employee participation in equity plans and can indicate positive sentiment regarding the company's long-term stock performance.

Detailed definition

Cash inflows resulting from the exercise of employee stock options or purchases through employee stock purchase plans. T...

Peer comparison

Standard for most publicly traded companies with equity-based compensation programs.

Metric ID: financing_proceeds_from_stock_plans

Historical Data

4 years
 FY'22FY'23FY'24FY'25
Value$182.00M$152.00M$221.00M$79.00M
YoY Change-16.5%+45.4%-64.3%
Range$79.00M$221.00M
CAGR-24.3%
Avg YoY Growth-11.8%
Median YoY Growth-16.5%

Frequently Asked Questions

What is Elevance Health's proceeds from issuance of common stock relating to employee stock plans?
Elevance Health (ELV) reported proceeds from issuance of common stock relating to employee stock plans of $19.75M in Q4 2025.
How has Elevance Health's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
Elevance Health's proceeds from issuance of common stock relating to employee stock plans decreased by 64.3% year-over-year, from $55.25M to $19.75M.
What is the long-term trend for Elevance Health's proceeds from issuance of common stock relating to employee stock plans?
Over 3 years (2022 to 2025), Elevance Health's proceeds from issuance of common stock relating to employee stock plans has grown at a -24.3% compound annual growth rate (CAGR), from $182.00M to $79.00M.
What does proceeds from issuance of common stock relating to employee stock plans mean?
Cash received from employees exercising stock options or buying company shares.